Neuropsychiatric disorders such as schizophrenia, bipolar disorder, and major depressive disorder are serious, debilitating, and clinically complex disorders that often pose a considerable challenge to clinicians. While practice guidelines may assist clinicians in management, clinical trial data is often rapidly emerging to identify evidence-based strategies to optimize clinical management.
Given the significant clinical and quality of life impact of neuropsychiatric disorders, the identification and implementation of safe, effective management strategies is paramount. Our Neuropsychiatric Hub is designed to provide clinicians with the latest practice guidelines, diagnostic strategies and tools, and scientific updates on current and emerging therapies to optimize management of neuropsychiatric disorders.
In this CME Outfitters live webcast, expert faculty will discuss the role of FcRn in the pathogenesis of gMG, evaluate the safety and efficacy of FcRn antagonists for the treatment of gMG, and provide expert guidance on how to identify patients with gMG who may be appropriate candidates for treatment with FcRn antagonists. Finally, they will model development of optimized and individualized treatment plans for patients with gMG receiving FcRn antagonists, providing learners with key skills to bring back to clinical practice.
In this CME Outfitters recorded symposium, expert faculty will discuss the disease burden and impact of LGS on QoL for patients and caregivers, the utilization of diagnostic criteria and distinguishing features of both early- and late-onset LGS to achieve early and accurate diagnosis, and strategies to optimize LGS management across the lifespan of these patients.
In this CME Outfitters podcast episode, expert faculty will discuss cultural and systemic challenges faced by ethnic/racially diverse patients, and empower health care professionals with education, tools, and resources to address these challenges and provide more equitable mental health care for all.
This downloadable resource is a template created by Epilepsy Alliance America to help in the creation of an acute seizure action plan for patients with Lennox-Gastaut syndrome.